Despite the fact that there are multiple etiologies of Alzheimer's disease (AD), all AD cases share the neuropathological hallmark of amyloid-Beta peptide (Abeta) plaques and neurofibrillary tangles in brain, indicating a possible common pathway of AD pathogenesis. Apolipoprotein E4 (ApoE4) has been identified as a major risk factor of late-onset AD, but approximately 50% of cases do not carry the ApoE4 allele. Interestingly, hyperinsulinaemia is found to be associated with AD cases in the absence of ApoE 4 influence. 37% of AD subjects suffer from impaired glucose tolerance, presumably also having elevated plasma insulin, compared to 19.9% of non-AD subjects in the same population. The major hypothesis of the proposed study is that hyperinsulinaemia is another risk factor of late-onset AD in the absence of ApoE4. Insulin and AB, the major component in AD pathology, share biochemical features. Both are short peptides with amyloidogenic properties, and both are degraded by a common protease, insulin-degrading enzyme (IDE). To explore the mechanism of how hyperinsulinaemia might contribute to AD, our secondary hypothesis is that in hyperinsulinaemia insulin competes with AB for IDE, increasing the amount AB and thus causing AD pathology. To translate the candidate's basic research on IDE and ABeta into clinical research on AD, this proposal presents a multi-faceted and collaborative study. By collaborating in a project that will recruit 1600 homebound elderly in Boston, subjects will be available to evaluate the relationship between insulin levels with cognitive impairment and AD. Subjects who do not carry ApoE4 and have not received insulin treatment will meet study criteria. Quantitative correlation will be evaluated between fasting plasma insulin level and cognitive impairment in the absence of ApoE4. Clinical examination and MRI scans will be performed on a subset of 473 subjects to evaluate the association of hyperinsulinaemia in AD vs. non-AD subjects. Hyperinsulinaemia is present in some but not all cases of type 2 diabetes. Because hyperinsulinaemia rather than type 2 diabetes alone may be the relevant risk factor of AD, the association of AD with hyperinsulinaemia vs. type 2 diabetes will also be analyzed. We will determine whether levels of insulin and cognitive function are correlated with Aa levels and IDE activity. Results from this study should provide a rationale to determine if elevated insulin increases the incidence of AD in a prospective study.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Mentored Patient-Oriented Research Career Development Award (K23)
Project #
1K23AG022476-01
Application #
6676098
Study Section
National Institute on Aging Initial Review Group (NIA)
Program Officer
Buckholtz, Neil
Project Start
2003-09-30
Project End
2008-08-31
Budget Start
2003-09-30
Budget End
2004-08-31
Support Year
1
Fiscal Year
2003
Total Cost
$128,684
Indirect Cost
Name
Tufts University
Department
Type
DUNS #
079532263
City
Boston
State
MA
Country
United States
Zip Code
02111
Zhu, Andrea Q; Kivork, Christine; Vu, Linh et al. (2017) The association between hope and mortality in homebound elders. Int J Geriatr Psychiatry 32:e150-e156
Mohamed, Loqman A; Zhu, Haihao; Mousa, Youssef M et al. (2017) Amylin Enhances Amyloid-? Peptide Brain to Blood Efflux Across the Blood-Brain Barrier. J Alzheimers Dis 56:1087-1099
Qiu, Wei Qiao; Himali, Jayandra J; Wolf, Philip A et al. (2017) Effects of white matter integrity and brain volumes on late life depression in the Framingham Heart Study. Int J Geriatr Psychiatry 32:214-221
Qiu, Wei Qiao; Zhu, Haihao; Dean, Michael et al. (2016) Amyloid-associated depression and ApoE4 allele: longitudinal follow-up for the development of Alzheimer's disease. Int J Geriatr Psychiatry 31:316-22
Mwamburi, Mkaya; Qiu, Wei Qiao (2016) Different associations of premorbid intelligencevs. current cognition with BMI, insulin and diabetes in the homebound elderly. Integr Mol Med 3:547-552
Li, Huajie; Zhu, Haihao; Wallack, Max et al. (2016) Age and its association with low insulin and high amyloid-? peptides in blood. J Alzheimers Dis 49:129-37
Zhu, H; Wang, X; Wallack, M et al. (2015) Intraperitoneal injection of the pancreatic peptide amylin potently reduces behavioral impairment and brain amyloid pathology in murine models of Alzheimer's disease. Mol Psychiatry 20:252-62
Qiu, Wendy Wei Qiao; Lai, Angela; Mon, Timothy et al. (2014) Angiotensin converting enzyme inhibitors and Alzheimer disease in the presence of the apolipoprotein E4 allele. Am J Geriatr Psychiatry 22:177-85
Qiu, Wei Qiao; Au, Rhoda; Zhu, Haihao et al. (2014) Positive association between plasma amylin and cognition in a homebound elderly population. J Alzheimers Dis 42:555-63
Qiu, Wei Qiao; Wallack, Max; Dean, Michael et al. (2014) Association between amylin and amyloid-? peptides in plasma in the context of apolipoprotein E4 allele. PLoS One 9:e88063

Showing the most recent 10 out of 30 publications